These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7571)

  • 41. Sustained elevation of serum prolactin by metoclopramide: a clinical model of idiopathic hyperprolactinemia.
    Healy DL; Burger HG
    J Clin Endocrinol Metab; 1978 May; 46(5):709-14. PubMed ID: 122286
    [No Abstract]   [Full Text] [Related]  

  • 42. Oxytocin does not modify the prolactin response to metoclopramide in normal women.
    Chiodera P; Volpi R; Gramellini D; Cigarini C; Corradi A; Cavazzini U; Bianconi L; Papadia C; Caiazza A; Capretti L
    J Endocrinol Invest; 1991 Jun; 14(6):463-8. PubMed ID: 1774442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia.
    Lissoni P; Mandalà M; Rovelli F; Casu M; Rocco F; Tancini G; Scardino E
    Eur Urol; 2000 May; 37(5):569-72. PubMed ID: 10765095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of metoclopramide on prolactin secretion in amyotrophic lateral sclerosis].
    Szulc-Kuberska J; Stepień H; Klimek A; Cieślak D
    Pol Tyg Lek; 1987 Nov; 42(45):1419-20. PubMed ID: 3447105
    [No Abstract]   [Full Text] [Related]  

  • 45. Thioridazine stimulates prolactin secretion in man.
    Sachar EJ; Gruen PH; Karasu TB; Altman N; Frantz AG
    Arch Gen Psychiatry; 1975 Jul; 32(7):885-6. PubMed ID: 239662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolactin secretion in Parkinson disease.
    Eisler T; Thorner MO; MacLeod RM; Kaiser DL; Calne DB
    Neurology; 1981 Oct; 31(10):1356-9. PubMed ID: 6810204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of physiologic and pharmacologic agents on serum prolactin concentrations in the nonpregnant mare.
    Johnson AL; Becker SE
    J Anim Sci; 1987 Nov; 65(5):1292-7. PubMed ID: 3121569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of exogenous monoiodotyrosine on the serum levels of anterior pituitary hormones.
    Tan SA; Lewis JE; Berk LS; Wilcox RB
    Acta Endocrinol (Copenh); 1991 Mar; 124(3):251-7. PubMed ID: 1901432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment.
    Cabranes JA; Fuentenebro F; Recio MN; Borque M; Almoguera MI
    Int Pharmacopsychiatry; 1982; 17(1):1-7. PubMed ID: 6123489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laboratory assessment of prolactin status.
    Cowden EA; Ratcliffe WA; Beastall GH; Ratcliffe JG
    Ann Clin Biochem; 1979 May; 16(3):113-21. PubMed ID: 117734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the dopa decarboxylase inhibitor MK-486 on L-dopa-induced inhibition of prolactin secretion: evidence for CNS participation in the L-dopa effects.
    Szabo M; Nakawatase C; Kovathana N; Frohman LA
    Neuroendocrinology; 1977; 24(1):24-34. PubMed ID: 600362
    [No Abstract]   [Full Text] [Related]  

  • 52. Abnormalities in the regulation of prolactin in patients with chronic renal failure.
    Ramirez G; O'Neill WM; Bloomer HA; Jubiz W
    J Clin Endocrinol Metab; 1977 Oct; 45(4):658-61. PubMed ID: 410821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Stimulation tests of prolactin secretion in the diagnosis of hypothalamic and pituitary diseases].
    Marek J; Srámková J
    Vnitr Lek; 1977 Sep; 23(10):976-87. PubMed ID: 411249
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of a psychoactive drug, trazodone, on prolactin secretion in man.
    Rolandi E; Magnani G; Milesi GM; Barreca T
    Neuropsychobiology; 1981; 7(1):17-9. PubMed ID: 7465018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prolactin dynamics following transphenoidal hypophysectomy for metastatic carcinoma of the breast.
    McMillin JM; Seal US; Theologides A
    Cancer; 1977 May; 39(5):2254-7. PubMed ID: 404030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of metoclopramide on prolactin secretion in patients with primary hypothyroidism].
    Dorobek W; Jeske W; Lazicka-Frelek M
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):973-5. PubMed ID: 6504724
    [No Abstract]   [Full Text] [Related]  

  • 57. Further evidence on the direct action of L-Dopa on prolactin release.
    Donoso AO; Banzán AM; Barcaglioni JC
    Neuroendocrinology; 1974; 15(3-4):236-9. PubMed ID: 4420786
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of research on control of prolactin secretion.
    Meites J
    Adv Exp Med Biol; 1977; 80():135-52. PubMed ID: 19945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamic evaluation of prolactin secretion in patients with oligospermia: effects of treatment with metergoline.
    Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
    Fertil Steril; 1979 Jan; 31(1):63-7. PubMed ID: 105938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Serum prolactin concentration after metoclopramide stimulation in patients with polycystic ovary syndrome].
    Baranowska B; Jeske W; Stopińska-Głuszak U
    Endokrynol Pol; 1983; 34(1):55-60. PubMed ID: 6347673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.